NCT02094274View on ClinicalTrials.gov

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Asthma
Interventions
DRUG

LAS40468

DRUG

Salmeterol/fluticasone propionate

DRUG

Placebo

Trial Locations (2)

14050

Almirall Investigational Site #1, Berlin

HA1 3UJ

Almirall Investigational Site #2, Harrow

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY

NCT02094274 - A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid | Biotech Hunter | Biotech Hunter